The bullish case for Applied Genetic Technologies Corp (NASDAQ: AGTC), a nano-cap biotech conducting human clinical trials of adeno-associated virus-based gene therapies, can be made on the basis of an encouraging pipeline and valuation reasons, according to Wells Fargo.
The Analyst
Wells Fargo... Read More...
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to: